How Can We Help You?

Not all validation is the same. When you partner with ValSource, you partner with leaders in risk management, process validation, and continued verification. We stand with you every step of the way.

ValSource Corporate Contact Information

  • 610.269.2808
  • 918A Horseshoe Pike,
    Downingtown, PA 19335

Executive Team & Board

Our executive team and corporate board features highly experienced pioneers in mechanical, chemical, electrical and validation engineering, computer, chemical and life sciences, process development, applied statistics, and operations.

Whitney Kutney - Chief Executive Officer

Whitney Kutney is the Chief Executive Officer at ValSource, Inc.

As CEO of ValSource, Ms. Kutney oversees all business operations. She has nearly 20 years of experience in the pharmaceutical, medical device, and biotech fields encompassing execution activities, management of complex projects, and business oversight. Ms. Kutney holds a Chemical Engineering degree from the University of Notre Dame.

Hal Baseman - COO and Director

Hal Baseman is the Chief Operating Officer and Director at ValSource, Inc.

Hal Baseman is the Chief Operating Officer and a Director at ValSource Inc. He has over 40 years of experience in pharmaceutical operations, validation, and regulatory compliance. He has held positions in executive management and technical operations at several drug manufacturing and consulting firms. He is the former chair of the PDA Board of Directors, former chair of the PDA Science Advisory Board, former co-leader of the PDA Process Validation Interest Group, and co-leader of the PDA Aseptic Processing Points to Consider and Annex 1 Commenting Task Forces, as well as a long-time member of the PDA Training Research Institute faculty. Baseman holds an MBA in management from LaSalle University and a B.S. in biology from Ursinus College.

Corinn White - Chief Financial Officer

Corrin White is the Chief Financial Officer at ValSource, Inc.

Ms. White joined ValSource in 2012. Her responsibilities include assisting in performing all tasks necessary to achieve the organization’s mission and growth plans as part of the management team. She also is responsible for preparing and overseeing fiscal reporting activities as well as analyze and build financial records to improve and accurately report the Company’s financial position.

David Calvaresi - Chairman of the Board

David Calvaresi is the Chairman of the Board at ValSource, Inc.

Mr. Calvaresi is the founder of ValSource. He has over 30 years of experience related to the operation and validation of pharmaceutical facilities. This includes three years of operational experience supervising manufacturing and process development at a major biotechnology company.

Board of Directors

ValSource, Inc. Board of Directors

Hal Baseman:
Hal Baseman is the Chief Operating Officer and a Director at ValSource Inc. He has over 40 years of experience in pharmaceutical operations, validation, and regulatory compliance. He has held positions in executive management and technical operations at several drug manufacturing and consulting firms. He is the former chair of the PDA Board of Directors, former chair of the PDA Science Advisory Board, former co-leader of the PDA Process Validation Interest Group, and co-leader of the PDA Aseptic Processing Points to Consider and Annex 1 Commenting Task Forces, as well as a long-time member of the PDA Training Research Institute faculty.

David Calvaresi:

Mr. Calvaresi is the founder of ValSource. He has over 30 years of experience related to the operation and validation of pharmaceutical facilities. This includes three years of operational experience supervising manufacturing and process development at a major biotechnology company.

Diane Blumenthal:

Diane joins the ValSource board of directors with more than 35 years of experience in biopharmaceutical process and product development, clinical and commercial manufacturing, quality control, scientific facilities, program management, and CMC regulatory. Former SVP/Head of Technical Operations at Spark Therapeutics, Ms. Blumenthal is skilled in building and transitioning companies from a start-up research and development organization to a fully integrated biopharmaceutical company with approved commercial manufacturing operations and products. Throughout her career, Ms. Blumenthal has played a key role in the development and commercialization of several well-known pharmaceutical products.

Katherine Oates:

Katherine brings over 25 years of human resources executive experience to the board of directors at ValSource. Ms. Oates is currently the VP of Human Resources for GlaxoSmithKline’s US Pharmaceuticals business. Throughout Ms. Oates’ career with GSK, she has worked with multiple businesses in a variety of HR leadership roles. Ms. Oates’ primary focus throughout her career has been enhancing organizational effectiveness through talent management, workforce engagement, leadership development, and culture.

Robert Radie:

Robert joins the ValSource board of directors with three decades of experience working in both public and private pharmaceutical and biotech companies, and across a range of therapeutic areas. Mr. Radie is currently the Chairman of the Board and CEO at Neuraptive Therapeutics, he has also held senior executive positions in six companies, including serving as Chief Executive Officer of Zyla Life Sciences, Inc. Transmolecular Inc, and Topaz Pharmaceuticals, Inc., which was acquired by Sanofi Pasteur. Mr. Radie also currently serves on the board of directors of several companies, including Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK), and Rockwell Medical Technologies Inc. (NASDAQ: RMTI).

We provide swift, agile solutions to support the end objective.